- Home
- SOS vs ALLR Comparison
SOS vs ALLR Comparison
Compare SOS & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- ALLR
- Stock Information
- Founded
- SOS 2004
- ALLR 2004
- Country
- SOS China
- ALLR United States
- Employees
- SOS N/A
- ALLR N/A
- Industry
- SOS Finance: Consumer Services
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- SOS Finance
- ALLR Health Care
- Exchange
- SOS Nasdaq
- ALLR Nasdaq
- Market Cap
- SOS 17.0M
- ALLR 15.8M
- IPO Year
- SOS 2017
- ALLR N/A
- Fundamental
- Price
- SOS $8.48
- ALLR $1.01
- Analyst Decision
- SOS
- ALLR
- Analyst Count
- SOS 0
- ALLR 0
- Target Price
- SOS N/A
- ALLR N/A
- AVG Volume (30 Days)
- SOS 62.3K
- ALLR 413.4K
- Earning Date
- SOS 05-15-2025
- ALLR 08-04-2025
- Dividend Yield
- SOS N/A
- ALLR N/A
- EPS Growth
- SOS N/A
- ALLR N/A
- EPS
- SOS N/A
- ALLR N/A
- Revenue
- SOS $231,424,000.00
- ALLR N/A
- Revenue This Year
- SOS N/A
- ALLR N/A
- Revenue Next Year
- SOS N/A
- ALLR N/A
- P/E Ratio
- SOS N/A
- ALLR N/A
- Revenue Growth
- SOS 150.42
- ALLR N/A
- 52 Week Low
- SOS $4.04
- ALLR $0.61
- 52 Week High
- SOS $15.51
- ALLR $7.45
- Technical
- Relative Strength Index (RSI)
- SOS 72.31
- ALLR 53.22
- Support Level
- SOS $6.06
- ALLR $0.95
- Resistance Level
- SOS $9.62
- ALLR $1.08
- Average True Range (ATR)
- SOS 0.62
- ALLR 0.07
- MACD
- SOS 0.29
- ALLR 0.01
- Stochastic Oscillator
- SOS 72.17
- ALLR 59.39
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.